Alzheimer's drug 'halts' decline (BBC)

[eppur_se_muova]

By Emma Wilkinson
Health reporter, BBC News

UK scientists have developed a drug which may halt the progression of Alzheimer's disease.

Trials of the drug, known as rember, in 321 patients showed an 81% difference in rate of mental decline compared with those not taking the treatment.

The Aberdeen University researchers said the drug targeted the build-up of a specific protein in the brain.

Alzheimer's experts were optimistic about the results, but said larger trials were now needed.

Presenting the results at the International Conference on Alzheimer's Disease, Professor Claude Wischik said the drug may be on the market by 2012.
***
more: http://news.bbc.co.uk/2/hi/health/7525115.stm

[Taverner]

1. And that drug is Cannabis Sativa

http://news.bbc.co.uk/2/hi/health/4286435.stm

http://www.newscientist.com/channel/being-human/drugs-alcohol/dn10330-hope-for-cannabisbased-drug-for-alzheimers.html

http://www.naturalnews.com/020667.html

[Betsy Ross]

2. And I was worried that THC might increase the risks. eom

[Taverner]

3. That's what they would have wanted you to beleive

They also used to say things like "we don't know the long term effects!" BS! People have smoked it for years and did just fine.

[stray cat]

4. The drug methylthioninium chloride (a blue dye in lab exps)

Rember, or methylthioninium chloride, is the first treatment specifically designed to target the Tau tangles.

Other treatments for Alzheimer's tend to focus on combating a waste protein in the brain, beta-amyloid, which is known to form hard plaques. The latest work suggests targeting Tau may produce better results.

Methylthioninium chloride is more commonly used as a blue dye in laboratory experiments.